These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1625 related articles for article (PubMed ID: 16182882)

  • 21. Definitions of metabolic syndrome: Where are we now?
    Daskalopoulou SS; Athyros VG; Kolovou GD; Anagnostopoulou KK; Mikhailidis DP
    Curr Vasc Pharmacol; 2006 Jul; 4(3):185-97. PubMed ID: 16842136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.
    ; Punthakee Z; Goldenberg R; Katz P
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S10-S15. PubMed ID: 29650080
    [No Abstract]   [Full Text] [Related]  

  • 23. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
    Grundy SM; Brewer HB; Cleeman JI; Smith SC; Lenfant C; ;
    Circulation; 2004 Jan; 109(3):433-8. PubMed ID: 14744958
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic determinants of diabetes and atherosclerosis.
    Mitchell BD; Imumorin IG
    Curr Atheroscler Rep; 2002 May; 4(3):193-8. PubMed ID: 11931716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones.
    Greenberg AS
    J Diabetes Complications; 2003; 17(4):218-28. PubMed ID: 12810246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome: an evolving threat in the genesis of coronary artery disease.
    Jain P; Lahiri A
    J Cardiometab Syndr; 2007; 2(3):190-7. PubMed ID: 17786083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classification criteria and clinical significance of the metabolic syndrome].
    Corbatón Anchuelo A; Serrano Ríos M
    Rev Clin Esp; 2006 Oct; 206(9):447-50. PubMed ID: 17042987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome in north Indian type 2 diabetes mellitus patients: A comparison of four different diagnostic criteria of metabolic syndrome.
    Gahlan D; Rajput R; Singh V
    Diabetes Metab Syndr; 2019; 13(1):356-362. PubMed ID: 30641725
    [No Abstract]   [Full Text] [Related]  

  • 30. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should we dump the metabolic syndrome? No.
    Alberti KG; Zimmet PZ
    BMJ; 2008 Mar; 336(7645):641. PubMed ID: 18356232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cardiometabolic syndrome and cardiovascular disease in racial and ethnic minorities: new areas of research and intervention.
    Ferdinand KC
    J Cardiometab Syndr; 2007; 2(4):235-7. PubMed ID: 18059204
    [No Abstract]   [Full Text] [Related]  

  • 33. The metabolic syndrome and the risk of thrombosis.
    Dentali F; Romualdi E; Ageno W
    Haematologica; 2007 Mar; 92(3):297-9. PubMed ID: 17339177
    [No Abstract]   [Full Text] [Related]  

  • 34. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE).
    Anand SS; Yusuf S; Vuksan V; Devanesen S; Teo KK; Montague PA; Kelemen L; Yi C; Lonn E; Gerstein H; Hegele RA; McQueen M
    Lancet; 2000 Jul; 356(9226):279-84. PubMed ID: 11071182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Misclassification of cardiometabolic health when using body mass index categories.
    Caleyachetty R; Meunnig P; Kengne AP
    Int J Obes (Lond); 2016 Aug; 40(8):1332. PubMed ID: 27102047
    [No Abstract]   [Full Text] [Related]  

  • 36. Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.
    Rosenson RS; Reasner CA
    Curr Opin Cardiol; 2004 Sep; 19(5):480-7. PubMed ID: 15316457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic syndrome and cardiovascular diseases].
    Shimamoto K
    Nihon Naika Gakkai Zasshi; 2008 Mar; 97(3):591-7. PubMed ID: 22675763
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin resistance syndrome and polycystic ovary syndrome.
    Nestler JE
    Endocr Pract; 2003; 9 Suppl 2():86-9. PubMed ID: 14698983
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
    Kakoly NS; Moran LJ; Teede HJ; Joham AE
    Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A physiological basis for disparities in diabetes and heart disease risk among racial and ethnic groups.
    Ludwig DS; Ebbeling CB; Pereira MA; Pawlak DB
    J Nutr; 2002 Sep; 132(9):2492-3. PubMed ID: 12221199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.